Feb. 11, 2014

Hydroxycloroquine May Help Prevent APS Pregnancy Complications

Vikki Abrahams, PhD, Associate Professor, Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine, discusses data from her study that was supported by the Lupus Foundation of America national lupus research program.  The study looked at the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome.   Read more about this study.


Related Stories

Podcasts | Nov. 05, 2013

Pregnancy Complications in Lupus: Retrospective Analysis from a U.S. Health Claims Database

Data obtained from a large insurance claims database highlights the need for specific education and counseling to pregnant women with lupus as well as close collaboration between the rheumatologist and the obstetrician throughout the pregnancy

Podcasts | Nov. 05, 2013

New Research Gives Insight for Improving Future Lupus Clinical Trials

Dr. Kenneth Kalunian discusses the Lupus Foundation of America Collective Data Analysis Initiative (LFA CDAI) which is providing insight into the impact various background medications may have on lupus clinical trial outcomes.